Gilead Sciences reported $87.58B in Market Capitalization for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 190.63B 8.32B
Acorda Therapeutics ACOR:US $ 51.17M 5.91M
Agios Pharmaceuticals AGIO:US $ 2.72B 672.75M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
ALKERMES ALKS:US 4.98B 1.04B
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Amgen AMGN:US $ 120.75B 19.29B
Arena Pharmaceuticals ARNA:US $ 3.64B 526.29M
Biogen BIIB:US $ 42.17B 9.96B
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Bluebird Bio BLUE:US $ 1.29B 865.55M
Bristol Myers Squibb BMY:US $ 131.34B 17.15B
Coherus Biosciences CHRS:US $ 1.23B 181.38M
Eli Lilly And LLY:US $ 221.02B 902.49M
Gilead Sciences GILD:US $ 87.58B 1.22B
GlaxoSmithKline GSK:LN 70.63B 794.04M
Glaxosmithkline GSK:US 95.15B 3.61B
Intercept Pharmaceuticals ICPT:US $ 493.04M 169.99M
Johnson & Johnson JNJ:US $ 425145.86M 8679.8M
Merk MRK:US $ 190131.55M 6786.63M
Moderna Inc MRNA:US $ 155.35B 61B
Neurocrine Biosciences NBIX:US $ 9.08B 123.68M
Novartis NOVN:VX 187.04B 20.99B
Pfizer PFE:US $ 241143.67M 21937.97M
Ptc Therapeutics PTCT:US $ 2.63B 355.33M
Puma Biotechnology PBYI:US $ 286.61M 83.91M
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Sangamo Biosciences SGMO:US $ 1.31B 412.77M
Sanofi SAN:FP 104.97B 6.43B
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Teva Pharmaceutical Industries TEVA:US 10.85B 134.37M
United Therapeutics UTHR:US $ 8.29B 249.36M
Vertex Pharmaceuticals VRTX:US $ 47.06B 5.14B
YTE INCY:US $ 15.19B 3.31B